Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05024695 · ClinicalTrials.gov registry record · NA

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

A NA study of Glaucoma, sponsored by iSTAR Medical.

Active
Registry status
NA
Development phase
975
Enrollment target
20
Study locations

NCT05024695 is a NA study of Glaucoma that is active but no longer recruiting, run by iSTAR Medical. The registered enrollment target is 975 participants, roughly in line with the 900-participant average among 92 other Glaucoma trials with a reported enrollment target. The trial reports 20 study locations across 17 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05024695, a NA study of Glaucoma, is active but no longer recruiting, sponsored by iSTAR Medical.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
975 participants
Enrollment target
20
Study locations

Study Summary

Evaluate the safety and effectiveness of iSTAR Medical's MINIject™ implant for lowering intraocular pressure (IOP) in subjects with primary open-angle glaucoma.

Conditions Studied

Interventions

  • DEVICE MINIject™ Implant

Study Locations (20)

California

  • Beverly Hills Institute of Ophthalmology - Beverly Hills
  • Reeve Woods Eye Center - Chico
  • Sacramento Eye Consultants, A Medical Corporation - Sacramento

Illinois

  • Illinois Eye Center - Peoria
  • Virdi Eye Clinic - Rock Island

Arizona

  • Arizona Advanced Eye Research Institute - Glendale

Arkansas

  • Vold Vision - Fayetteville

Colorado

  • Grand Junction Eye Care - Grand Junction

Florida

  • Eye Associates of Fort Myers - Fort Myers

Idaho

  • Intermountain Eye Center - Eagle

Kansas

  • Stiles Eyecare Excellene and Glaucoma Institute - Overland Park

Trial Details

FieldValue
Enrollment Target 975 participants
Start Date 2021-08-19
Est. Completion 2029-07
Phase NA

Sponsor

iSTAR Medical

1 total trials

What the Registry Record Tells You About NCT05024695

The ClinicalTrials.gov registry entry for NCT05024695 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 975 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 900-participant average among 92 other Glaucoma trials with a reported enrollment target. The listed sponsor is iSTAR Medical, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which MINIject™ Implant is the first listed.

NCT05024695 reports 20 study locations spanning 17 distinct geographic areas - top geographies include California, Illinois, Arizona.

Frequently Asked Questions

What is clinical trial NCT05024695 about?

NCT05024695 is a clinical study titled "Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.". Evaluate the safety and effectiveness of iSTAR Medical's MINIject™ implant for lowering intraocular pressure (IOP) in subjects with primary open-angle glaucoma.

What is the current status of trial NCT05024695?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 975 participants. The study started on 2021-08-19. Estimated completion is 2029-07.

What conditions does trial NCT05024695 study?

This clinical trial studies the following conditions: Glaucoma.

What interventions are being tested in trial NCT05024695?

The interventions under investigation include: MINIject™ Implant (DEVICE).

Who is sponsoring clinical trial NCT05024695?

This trial is sponsored by iSTAR Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05024695 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.